President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Pentagon Ends Military Education Programs With Harvard University
U.S. Sanctions on Russia Could Expand as Ukraine Peace Talks Continue, Says Treasury Secretary Bessent
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border 



